老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

35.98
+2.567.66%
盘后：35.30-0.6800-1.89%17:23 EDT
成交量：183.54万
成交额：6,526.33万
市值：33.76亿
市盈率：-6.12
高：36.85
开：33.13
低：33.13
收：33.42
数据加载中...
总览公司新闻公告
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/04/16

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

重要事件披露

8-K - Current report
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2021/01/08

重要事件披露

8-K - Current report
2020/12/17

重要事件披露

8-K - Current report
2020/12/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/07

重要事件披露

8-K - Current report
2020/11/06

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
更多